Close Menu

DNAnexus

Enzymatics has launched SPARK sample prep kits for Illumina and Life Technologies' Ion Torrent sequencing platforms.

This week, Firefly BioWorks released PubmiR, a free search engine for microRNA pathways.

Developers of InSilico DB, a publicly available repository of genomic datasets, are preparing to offer a commercial service based on the resource that will offer paying customers the chance to compare their proprietary RNA sequence data with public information and analyze it usin

Maverix Biomics, a San Mateo, Calif.-based bioinformatics startup, this week launched the first version of the Maverix Analytic Platform, a cloud-based offering for next-generation sequence data management, exploration, and visualization.

Emerging from stealth mode, newly minted Five3 Genomics is hoping to claim a share of the bioinformatics marketplace by providing cancer genome analysis services using tools developed at the University of California, Santa Cruz.

Rubicon Genomics has hired Kenneth Solomon as director of sales and marketing. He has previously held positions at Centocor Ortho Biotech, Pharmacia/Searle, Biomet, and Boehringer Manheim.

DNANexus has appointed Marc Olesen to serve as president and chief operating officer.

Bioinformatics startup Omicia has appointed Leroy Hood and Paul Flicek to its scientific advisory board.

DNANexus said this week that it has signed an agreement with Geisinger Health System that should yield clinically relevant workflows for the use of genome sequence data in medicine.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – DNAnexus today announced deals with the Geisinger Health System and the University of California, San Francisco to develop clinically relevant workflows.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.